Andrew Cooper
Stock Analyst at Raymond James
(2.42)
# 2,479
Out of 4,954 analysts
147
Total ratings
45.04%
Success rate
-0.76%
Average return
Main Sectors:
Stocks Rated by Andrew Cooper
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Downgrades: Outperform | $105 → $78 | $54.45 | +43.25% | 10 | Aug 11, 2025 | |
| AZTA Azenta | Upgrades: Outperform | $35 | $29.77 | +17.57% | 2 | Aug 6, 2025 | |
| AVTR Avantor | Reiterates: Outperform | $16 → $14 | $12.88 | +8.70% | 15 | Aug 4, 2025 | |
| GH Guardant Health | Maintains: Outperform | $59 → $61 | $58.50 | +4.27% | 4 | Jul 31, 2025 | |
| RVTY Revvity | Reiterates: Outperform | $120 → $115 | $91.70 | +25.41% | 9 | Jul 29, 2025 | |
| ITGR Integer Holdings | Maintains: Outperform | $150 → $143 | $107.30 | +33.27% | 3 | Jul 25, 2025 | |
| TMO Thermo Fisher Scientific | Reiterates: Outperform | $525 → $535 | $494.81 | +8.12% | 7 | Jul 24, 2025 | |
| MYGN Myriad Genetics | Reiterates: Outperform | $19 → $10 | $5.53 | +80.83% | 5 | May 7, 2025 | |
| FLGT Fulgent Genetics | Reiterates: Outperform | $24 → $25 | $21.36 | +17.04% | 2 | May 5, 2025 | |
| HOLX Hologic | Reiterates: Outperform | $90 → $71 | $68.76 | +3.26% | 12 | May 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $219.39 | - | 1 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $211.40 | - | 8 | Feb 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Perform | n/a | $47.00 | - | 8 | Sep 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $12.17 | - | 16 | May 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $68 → $85 | $160.64 | -47.09% | 5 | Feb 20, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Outperform | $100 → $76 | $26.34 | +188.53% | 12 | Feb 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | n/a | $4.00 | - | 1 | Jul 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $6.10 | - | 14 | May 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $29.49 | - | 8 | Jan 18, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $2.90 | - | 5 | Sep 22, 2021 |
Haemonetics
Aug 11, 2025
Downgrades: Outperform
Price Target: $105 → $78
Current: $54.45
Upside: +43.25%
Azenta
Aug 6, 2025
Upgrades: Outperform
Price Target: $35
Current: $29.77
Upside: +17.57%
Avantor
Aug 4, 2025
Reiterates: Outperform
Price Target: $16 → $14
Current: $12.88
Upside: +8.70%
Guardant Health
Jul 31, 2025
Maintains: Outperform
Price Target: $59 → $61
Current: $58.50
Upside: +4.27%
Revvity
Jul 29, 2025
Reiterates: Outperform
Price Target: $120 → $115
Current: $91.70
Upside: +25.41%
Integer Holdings
Jul 25, 2025
Maintains: Outperform
Price Target: $150 → $143
Current: $107.30
Upside: +33.27%
Thermo Fisher Scientific
Jul 24, 2025
Reiterates: Outperform
Price Target: $525 → $535
Current: $494.81
Upside: +8.12%
Myriad Genetics
May 7, 2025
Reiterates: Outperform
Price Target: $19 → $10
Current: $5.53
Upside: +80.83%
Fulgent Genetics
May 5, 2025
Reiterates: Outperform
Price Target: $24 → $25
Current: $21.36
Upside: +17.04%
Hologic
May 2, 2025
Reiterates: Outperform
Price Target: $90 → $71
Current: $68.76
Upside: +3.26%
Mar 28, 2025
Initiates: Market Perform
Price Target: n/a
Current: $219.39
Upside: -
Feb 3, 2025
Downgrades: Market Perform
Price Target: n/a
Current: $211.40
Upside: -
Sep 26, 2024
Reiterates: Market Perform
Price Target: n/a
Current: $47.00
Upside: -
May 13, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $12.17
Upside: -
Feb 20, 2024
Downgrades: Outperform
Price Target: $68 → $85
Current: $160.64
Upside: -47.09%
Feb 14, 2024
Downgrades: Outperform
Price Target: $100 → $76
Current: $26.34
Upside: +188.53%
Jul 19, 2023
Initiates: Market Perform
Price Target: n/a
Current: $4.00
Upside: -
May 16, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $6.10
Upside: -
Jan 18, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $29.49
Upside: -
Sep 22, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $2.90
Upside: -